KPV 10 mg
Denotes the lysine-proline-valine tripeptide sequence.
CAD $56.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0091 Listed amount per vial: 10 mg Sales unit: 1 vial
Read the research in context.
Denotes the lysine-proline-valine tripeptide sequence.
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Provide supplier specification/SDS with exact identity (structure or sequence, stereochemistry/modifications and salt), active amount basis, excipients, physical form, packaging/fill, and lot-linked analytical evidence. No batch facts are verified by the catalogue alone. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for KPV, product reference MRD-0091.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 10 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.